COMMUNIQUÉS West-GlobeNewswire

Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum
09/09/2025
WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today [...]
Breckenridge Brewery Awarded Silver Certification by the Colorado Green Business Network for Excellence in Sustainability Practices
09/09/2025
LITTLETON, Colo., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Breckenridge Brewery , a craft brewery owned by Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY), is proud to announce it has received the Silver [...]
New Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions
09/09/2025
In the study, TissueCypher identified that 15% of patients with non-dysplastic Barrett's esophagus (NDBE) had a probability of progression that was similar to, or exceeded, progression rates associated with low-grade [...]
Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology (EADV) Congress
09/09/2025
- Late Breaking Abstract to Present Additional Data from Aclaris’ Phase 2a Trial of ATI-2138 in Atopic Dermatitis- WAYNE, Pa., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical- [...]
Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Improvements in Survival Outcomes for Advanced Non-small Cell Lung Cancer
09/09/2025
Late-breaking data from exploratory analyses at WCLC show Libtayo plus chemotherapy demonstrates a more than double five-year overall survival rate of 19.4%, compared to 8.8% with chemotherapy alone In a five-year [...]
Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments
09/09/2025
UnitedHealthcare’s Coverage Policy includes procedures enabled with OMNI Surgical System technology, the leader in implant-free MIGS, are proven and medically necessary MENLO PARK, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE [...]
Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference
09/09/2025
Appili Non-Clinical Director to join NATO and allied representatives and present ATI-1701 biodefense vaccine as a potential solution to the tularemia threat HALIFAX, Nova Scotia, Sept. 09, 2025 (GLOBE NEWSWIRE) -- [...]
Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness
09/09/2025
GAITHERSBURG, Md., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that a contract modification has been executed in the amount of $56 million to supply ACAM2000 ® , (Smallpox [...]
Xilio Therapeutics Announces Initiation of Phase 2 Trial for Efarindodekin Alfa (XTX301), a Tumor-Activated IL-12, and Achievement of $17.5 Million Development Milestone Under Exclusive License Agreement with Gilead
09/09/2025
Phase 1 data for efarindodekin alfa (XTX301) demonstrate promising anti-tumor activity in patients with advanced solid tumors Achievement of milestone extends anticipated cash runway into first quarter of 2027 WALTHAM, [...]
MAPS Board of Directors Names Betty Aldworth and Ismail Lourido Ali as Co-Executive Directors
09/09/2025
Betty Aldworth and Ismail Lourido Ali bring decades of combined experience in drug policy leadership, psychedelic advocacy, and movement building As Co-Executive Directors, Aldworth and Ali reflect MAPS' legacy [...]
Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial
09/09/2025
New clinical Precision Medicine population 48-week data demonstrates unprecedented cognitive stabilization in early Alzheimer’s disease Cognitive outcomes observed in the oral blarcamesine 30 mg Precision Medicine [...]
Aveanna to Participate at the Jefferies Healthcare Services Conference
09/09/2025
ATLANTA, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Jefferies Healthcare Services Conference in Nashville on [...]
Enlivex Announces Issuance of New Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis
09/09/2025
Nes-Ziona, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the issuance of an Israeli [...]
Hyperion DeFi Strengthens Leadership Team With Key Appointments to Accelerate DeFi Strategy
09/09/2025
Hyunsu Jung Named Interim CEO; CFO Appointment Confirmed, Underscoring Focus on Decentralized Finance Board Expansion and Continued Strategic Advisory Designed to Drive Growth and Execution LAGUNA HILLS, Calif., Sept. [...]
Arrivent Presents the Final Analysis of Firmonertinib Monotherapy Data from Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2025 World Conference on Lung Cancer
09/09/2025
16.0 months median progression free survival (mPFS) with firmonertinib 240 mg by blinded independent central review (BICR) in first-line patients Confirmed overall response rate (cORR) 68.2% and duration of response ( [...]
Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and Growth
09/09/2025
Renowned plastic surgeons, dermatologists, aesthetic practitioners, and estheticians to help guide product development, education, and clinical excellence as the Company deepens its partnership with providers LONG BEACH [...]
Peer Leadership and Resilience Shine in Military Veteran Alpine Challenge
09/09/2025
WHISTLER, British Columbia, Sept. 09, 2025 (GLOBE NEWSWIRE) -- On September 6th, the fourth annual Military Veteran Alpine Challenge (MVAC) was successfully completed in Whistler, British Columbia. Led by the Chronic [...]
Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
09/09/2025
HOUSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on September 4, 2025 the Company received notification from The Nasdaq Stock Market LLC [...]
Numab Therapeutics Announces Leadership Transition and Appoints Angehrn Pavik as Chief Executive Officer
09/09/2025
HORGEN, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Numab Therapeutics AG (“Numab”), a biotechnology company advancing a proprietary pipeline of multi-specific antibodies in immunology and oncology, today announced [...]

Pages